clinical trial · NCT07619872
KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance
Edwards Lifesciences·—·recruiting·n = 250
Aortic Valve DiseaseEdwards KONECT RESILIA AVC
brief summary
KONECTION is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in up to 250 participants who will receive the KONECT RESILIA aortic valved conduit, Model 11060A.
started
Jun 25, 2026
primary completion
Dec 31, 2028
completion
Jun 30, 2039
last updated
Jul 17, 2026
detailed description
Subjects in the KONECTION study will be enrolled at up to 20 sites in Europe and Canada. The population will be participants requiring replacement of their diseased native or prosthetic aortic valve, and the associated repair or replacement of a damaged or diseased ascending aorta.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol